Loading...
The use of daily bed baths with chlorhexidine gluconate (CHG) in the intensive care unit (ICU) has been found to decrease the incidence of central line–associated bloodstream infections, as well as infections caused by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci (VRE).
In a recent study partially funded by the manufacturer of CHG, researchers at the University of Nebraska Medical Center extended CHG patient bathing across their entire 689-bed institution. Using a quasi-experimental, dose-ranging, staged-introduction study design, they evaluated the effect of either daily or three-times-weekly CHG bathing on the incidence of healthcare-acquired infections.
From February 2009 through August 2010, 68,302 CHG …